|
RTF1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.03429999999982E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.736600E-03 |
| Normal-vs-Stage2 |
1.784120E-03 |
| Normal-vs-Stage3 |
3.8547000003053E-07 |
| Normal-vs-Stage4 |
2.09740000000069E-05 |
| Stage1-vs-Stage2 |
2.894800E-01 |
| Stage1-vs-Stage3 |
7.878400E-03 |
| Stage1-vs-Stage4 |
3.285500E-02 |
| Stage2-vs-Stage3 |
4.059600E-01 |
| Stage2-vs-Stage4 |
5.216400E-01 |
| Stage3-vs-Stage4 |
9.112000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.63850000000276E-05 |
| Normal-vs-AfricanAmerican |
2.656600E-03 |
| Normal-vs-Asian |
9.987400E-01 |
| Caucasian-vs-AfricanAmerican |
6.172000E-01 |
| Caucasian-vs-Asian |
1.395790E-01 |
| AfricanAmerican-vs-Asian |
1.881000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.80839999996962E-06 |
| Normal-vs-Female |
6.744600E-03 |
| Male-vs-Female |
1.308140E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.437950E-01 |
| Normal-vs-Age(41-60Yrs) |
1.401310E-03 |
| Normal-vs-Age(61-80Yrs) |
3.2455999999792E-06 |
| Normal-vs-Age(81-100Yrs) |
9.55280000000114E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.804200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.964600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.364160E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.130380E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.745800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.175560E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.591400E-01 |
| Normal-vs-Grade 2 |
2.395600E-02 |
| Normal-vs-Grade 3 |
3.74489994570126E-09 |
| Normal-vs-Grade 4 |
1.54280999999923E-05 |
| Grade 1-vs-Grade 2 |
3.347600E-02 |
| Grade 1-vs-Grade 3 |
5.8732999999922E-05 |
| Grade 1-vs-Grade 4 |
4.969300E-04 |
| Grade 2-vs-Grade 3 |
2.32550000001108E-06 |
| Grade 2-vs-Grade 4 |
6.180500E-03 |
| Grade 3-vs-Grade 4 |
5.716200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.455230E-03 |
| Normal-vs-ccB subtype |
3.002000E-04 |
| ccA subtype-vs-ccB subtype |
3.416600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.79970000000163E-05 |
| Normal-vs-N1 |
5.507600E-02 |
| N0-vs-N1 |
8.898400E-01 |
|
|
